Current advancements in Ab luminescent probes and inhibitors of Ab aggregation

ISSN: 1875-5828 (Online)
ISSN: 1567-2050 (Print)

Volume 12, 10 Issues, 2015

Download PDF Flyer

Current Alzheimer Research

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 38th of 194 in Clinical Neurology
  • 80th of 251 in Neurosciences

Submit Abstracts Online Submit Manuscripts Online

Prof. Debomoy K. Lahiri
Department of Psychiatry, Indiana University School of Medicine
Neuroscience Research Center
Indianapolis, IN 46202

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.796
5 - Year: 3.998

Current advancements in Ab luminescent probes and inhibitors of Ab aggregation

Author(s): C-H Leung, DS-H Chan, VP-Y Ma, K-H Leung and H-J Zhong


Alzheimer’s disease (AD) is a neurodegenerative disorder that severely jeopardizes the health of aging populations all over the world. According to the amyloid cascade hypothesis, the pathological progression of AD is associated with the formation of amyloid plaques in the brain, resulting from the aggregation of amyloid-b (Ab) peptides. Over the past few years, vast efforts have been dedicated to the development of amyloid probes and inhibitors for the diagnosis and effective treatment of AD. We review here recent advancements in luminescent probes for the detection of Ab peptide and fibrils, and the current development of small molecules inhibitors of Ab aggregation. We also highlight the key features in each specific example, as well as review new ideas and strategies that are crucial for researchers in this field.

Purchase Online Order Reprints Order Eprints Rights and Permissions


Article Details

Volume: 10
First Page: 1
Page Count: 1
DOI: 10.2174/15672050113109990010

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science